BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 36109667)

  • 21. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recommendations on the diagnosis and treatment of anti-neutrophil cytoplasmic antibody associated vasculitis in China].
    Tian XP; Zhao LK; Jiang ZY; Wang Y; Huang CB; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1128-1135. PubMed ID: 36207967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Key advances in the clinical approach to ANCA-associated vasculitis.
    Kallenberg CG
    Nat Rev Rheumatol; 2014 Aug; 10(8):484-93. PubMed ID: 24980139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
    Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
    PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
    Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
    Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
    Wallace ZS; Stone JH
    Front Immunol; 2019; 10():2855. PubMed ID: 31867013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis.
    Fernandes-Serodio J; Prieto-González S; Espígol-Frigolé G; Ríos-Garcés R; Gómez-Caverzaschi V; Araújo O; Espinosa G; Jordà-Sánchez R; Alba MA; Quintana L; Blasco M; Guillen E; Viñas O; Ruiz-Ortiz E; Pelegrín L; Sainz de la Maza M; Sánchez-Dalmau B; García-Herrera A; Solé M; Castillo P; Aldecoa I; Cano MD; Sellarés J; Hernández-González F; Agustí C; Lucena CM; López-Rueda A; Sánchez M; Benegas M; Capurro S; Sanmartí R; Grau JM; Vilaseca I; Alobid I; Cid MC; Hernández-Rodríguez J
    J Intern Med; 2024 May; 295(5):651-667. PubMed ID: 38462959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis (AAV): a concise review with emphasis on clinical and histopathologic correlation.
    Gibson LE
    Int J Dermatol; 2022 Dec; 61(12):1442-1451. PubMed ID: 35599359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ANCA-associated vasculitis: report from Korea.
    Kim HW; Song YW
    Clin Exp Nephrol; 2013 Oct; 17(5):708-711. PubMed ID: 23292177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ANCA-associated vasculitis.
    Kitching AR; Anders HJ; Basu N; Brouwer E; Gordon J; Jayne DR; Kullman J; Lyons PA; Merkel PA; Savage COS; Specks U; Kain R
    Nat Rev Dis Primers; 2020 Aug; 6(1):71. PubMed ID: 32855422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis.
    Ahn SS; Song JJ; Park YB; Lee SW
    Korean J Intern Med; 2022 Nov; 37(6):1241-1249. PubMed ID: 34883552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum of ANCA-specificities in eosinophilic granulomatosis with polyangiitis. A retrospective multicentre study.
    Arnold S; Mahrhold J; Kerstein-Staehle A; Riemekasten G; Csernok E; Hellmich B; Venhoff N; Thiel J; Affeldt K; Jahnke A; Lamprecht P
    Clin Exp Rheumatol; 2023 Apr; 41(4):936-942. PubMed ID: 37073637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ANCA Status or Clinical Phenotype - What Counts More?
    Windpessl M; Bettac EL; Gauckler P; Shin JI; Geetha D; Kronbichler A
    Curr Rheumatol Rep; 2021 Apr; 23(6):37. PubMed ID: 33909191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.